Morgan Stanley’s Top 5 Stock Picks For 2023

4. Zoetis Inc. (NYSE:ZTS)

Share Price Upside: 39%

Number of Hedge Fund Holders In Q4 2022: 58

Zoetis Inc. (NYSE:ZTS) is a healthcare company that focuses its efforts on making treatments for animals. The firm was previously a subsidiary of the pharmaceutical giant Pfizer.

Zoetis Inc. (NYSE:ZTS)’s fourth quarter of 2022 results, revealed in February 2023 saw the firm report $2 billion in revenue and $461 million in net income, enabling it to beat analyst revenue estimates. By the end of last year’s fourth quarter, 58 of the 943 hedge funds polled by Insider Monkey had invested in the company.

Zoetis Inc. (NYSE:ZTS)’s largest investor is William Von Mueffling’s Cantillon Capital Management which owns 1.8 million shares that are worth $266 million.

Follow Zoetis Inc. (NYSE:ZTS)